ZIOPHARM Oncology Inc (ZIOP) stock moves up, “Hold” rating reaffirmed by J P Morgan Chase & Co Analysts

ZIOPHARM Oncology Inc (NASDAQ: ZIOP) shares rose in early trading today on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.

Meanwhile, U.S. stocks opened significantly lower in early trading. The Dow Jones Industrial Average was 58 points lower, or 0.29% to 19895, the S&P 500 fell 7 points, or 0.28% to 2268, while the Nasdaq dropped 22 points, or 0.38% to 5542.

Analysts at J P Morgan Chase & Co reiterated a Hold rating on shares of ZIOPHARM Oncology Inc (NASDAQ: ZIOP) in a reserach note to investors, making it one of the more closely watched stocks on Wall Street. With a rating of Hold on the shares, the company has a 52-week high of $9.74. The one-year price target of $21.00 is higher than the opening price of $5.55, causing a fair amount of other analysts to issue statements on the stock recently. Stock prices often move to the upside on recommendations and new price targets of professional brokerage firms.

Shares of ZIOPHARM Oncology Inc (NASDAQ: ZIOP) opened at $5.55 yesterday trading between $5.45 and $5.56, and last traded at $5.47, a spike of $0.06 from the previous closing price.

ZIOPHARM Oncology Inc (NASDAQ: ZIOP) currently has a market cap of 713.16M.

ZIOPHARM Oncology Inc (NASDAQ: ZIOP) Average Daily Trading Volume

237,203 shares crossed the trading desk yesterday, 59 percent below the norm, out of a total float 106,687,000. lower than normal. Look for trading volume to pick up in the coming days as swing traders often use upticks in trading volume to identify heavy volume accumulation or distribution by institutional investors.

However, a single day of heavy buy side trading is not enough to assert a trend. As such, market traders will continue to watch for institutional sponsorship as a signal that financial institutions are moving forward.

Institutional sponsorship commonly refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These instituitional investors have teams of analysts researching thousands of stocks. Thus, watching their interests is a good way to make sure you are buying the right stocks.

ZIOPHARM Oncology Inc (NASDAQ: ZIOP) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By tracking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more effective decisions on trades.

With that in mind, ZIOPHARM Oncology Inc (NASDAQ: ZIOP) now has a 50-day MA of $6.20 and 200-day MA of $5.68. It has traded in a 52-week range between $4.45 – 9.740 and today’s last price is 43.89%% lower than the 52 week high of $9.74.

Earnings growth is a critical factor to research when investing in stocks and investors identify companies that have grown their earnings by at least 25% for a 3 year period.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply